Financials
| Trading Update | Oct. 16, 2025 |
| Trading Update | Jul. 17, 2025 |
| Half-year Report | May. 20, 2025 |
| Trading Update | Apr. 16, 2025 |
| Financial Results for year ended 30 September 2024 | Dec. 04, 2024 |
| Trading Update | Aug. 14, 2024 |
| Half-year Report | May. 21, 2024 |
Proxies
| Result of AGM | Jan. 24, 2025 |
| Result of AGM | Jan. 25, 2024 |
| Result of AGM | Jan. 27, 2023 |
| Result of AGM | Jan. 20, 2022 |
| Result of AGM | Jan. 21, 2021 |
| Result of AGM | Jan. 18, 2019 |
| Result of AGM | Jan. 22, 2018 |
Ownership Update
| Share option awards and PDMR Dealing | Jun. 13, 2025 |
| Holding(s) in Company | May. 20, 2025 |
| Holding(s) in Company | May. 08, 2025 |
| Issue of share options and PDMR dealing | Feb. 07, 2025 |
| Share Option Award & PDMR Dealings | Dec. 04, 2024 |
| Share Option Awards & PDMR Dealing | Oct. 31, 2024 |
| Holding(s) in Company | Oct. 30, 2024 |
Announcements
| Financial Results for year ended 30 September 2025 | Dec. 09, 2025 |
| Operational Update | Dec. 01, 2025 |
| Notice of 2025 Full Year Results and IMC | Nov. 27, 2025 |
| Clinical Trial Contract Win | Nov. 17, 2025 |
| New contract win and contract extension | Oct. 15, 2025 |
| Notice of Capital Markets Day | Sep. 30, 2025 |
| Contract Win | Aug. 12, 2025 |